Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,413,672
  • Shares Outstanding, K 400,525
  • Annual Sales, $ 803,400 K
  • Annual Income, $ -747,060 K
  • 60-Month Beta 1.39
  • Price/Sales 79.70
  • Price/Cash Flow N/A
  • Price/Book 24.72
Trade MRNA with:

Options Overview

Details
  • Implied Volatility 68.84%
  • Historical Volatility 71.18%
  • IV Percentile 7%
  • IV Rank 14.27%
  • IV High 139.76% on 04/20/20
  • IV Low 57.04% on 03/23/21
  • Put/Call Vol Ratio 0.40
  • Today's Volume 171,797
  • Volume Avg (30-Day) 51,615
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 489,342
  • Open Int (30-Day) 365,185

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.62
  • Number of Estimates 6
  • High Estimate 4.26
  • Low Estimate 1.95
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +848.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
117.34 +45.57%
on 03/30/21
171.92 -0.65%
on 04/16/21
+14.79 (+9.48%)
since 03/16/21
3-Month
117.34 +45.57%
on 03/30/21
189.26 -9.75%
on 02/08/21
+41.16 (+31.75%)
since 01/15/21
52-Week
43.11 +296.22%
on 04/21/20
189.26 -9.75%
on 02/08/21
+130.21 (+320.71%)
since 04/16/20

Most Recent Stories

More News
Stocks Jump 1% This Week as Earnings and Data Outperform

Stocks Jump 1% This Week as Earnings and Data Outperform

LEN : 105.88 (+2.88%)
TSCO : 181.08 (+2.34%)
NDAQ : 160.17 (+0.07%)
SOHU : 19.28 (+4.95%)
DGII : 18.34 (-1.98%)
ICLK : 11.93 (+7.48%)
NVAX : 227.35 (+12.50%)
MRNA : 170.81 (+6.84%)
MS : 78.59 (-2.76%)
PNC : 178.86 (+2.33%)
JPM : 153.30 (+0.74%)
WFC : 43.84 (+3.79%)
GS : 342.31 (+1.11%)
BAC : 39.15 (+1.06%)
C : 72.45 (-0.12%)
NFLX : 546.54 (-0.49%)
Moderna to Report First Quarter Financial Results on Thursday, May 6, 2021

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on...

MRNA : 170.81 (+6.84%)
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

Moderna (MRNA) closed the most recent trading day at $159.87, moving -0.1% from the previous trading session.

MRNA : 170.81 (+6.84%)
Moderna (MRNA) Gives Pipeline Update, to Initiate New Pivotal Study

Moderna (MRNA) is developing 14 mRNA-based vaccine candidates in different stages of clinical development. Interim data from ongoing cytomegalovirus and RSV vaccine studies are promising.

JNJ : 162.24 (+1.15%)
PFE : 38.57 (+2.58%)
MRNA : 170.81 (+6.84%)
BNTX : 151.54 (+7.69%)
SMART Global, General Motors, Moderna, BioNTech and Johnson & Johnson highlighted as Zacks Bull and Bear of the Day

SMART Global, General Motors, Moderna, BioNTech and Johnson & Johnson highlighted as Zacks Bull and Bear of the Day

JNJ : 162.24 (+1.15%)
MRNA : 170.81 (+6.84%)
GM : 58.71 (+0.17%)
SGH : 56.59 (+0.11%)
BNTX : 151.54 (+7.69%)
Moderna, Valero rise; Stitch Fix, Discovery fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:

GS : 342.31 (+1.11%)
SAP : 139.30 (+0.07%)
MRNA : 170.81 (+6.84%)
VLO : 72.50 (+1.55%)
NKLA : 10.98 (+3.29%)
DISCA : 37.34 (-1.27%)
SFIX : 46.58 (+4.04%)
KSS : 59.41 (+0.27%)
JNJ Vaccine Pause Gives Stay-at-Home ETFs a Shot in the Arm

The U.S. regulators recommended an immediate pause on the use of Johnson & Johnson's (JNJ) COVID- 19 vaccine over reports of a "rare and severe type of blood clot" in six out of millions vaccinated.

JNJ : 162.24 (+1.15%)
PFE : 38.57 (+2.58%)
MRNA : 170.81 (+6.84%)
ARKW : 155.41 (-1.42%)
WCLD : 51.98 (-1.27%)
BUG : 27.21 (-0.55%)
IWFH : 29.98 (-0.56%)
Geron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat

Geron (GERN) is evaluating its lead pipeline candidate, imetelstat, in late-stage studies for refractory myelofibrosis and myelodysplastic syndromes.

MRNA : 170.81 (+6.84%)
GERN : 1.4700 (-2.65%)
AVIR : 44.94 (-2.33%)
CDMO : 19.16 (-1.64%)
Thinking about trading options or stock in Tesla, Moderna, Novavax, Snap, or Nio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TSLA, MRNA, NVAX, SNAP, and NIO.

MRNA : 170.81 (+6.84%)
NVAX : 227.35 (+12.50%)
TSLA : 739.78 (+0.13%)
NIO : 36.09 (+1.21%)
SNAP : 61.25 (-4.13%)
Stock Market News for Apr 14, 2021

The S&P 500 and the Nasdaq closed in the green on Tuesday backed by solid gains in tech stocks.

MSFT : 260.74 (+0.48%)
NKE : 134.31 (+0.48%)
IBM : 133.59 (+0.76%)
JNJ : 162.24 (+1.15%)
AAPL : 134.16 (-0.25%)
MRNA : 170.81 (+6.84%)
TSLA : 739.78 (+0.13%)
TEAM : 234.76 (-1.83%)
OKTA : 269.98 (-1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 189.46
2nd Resistance Point 180.69
1st Resistance Point 175.75
Last Price 170.81
1st Support Level 162.04
2nd Support Level 153.27
3rd Support Level 148.33

See More

52-Week High 189.26
Last Price 170.81
Fibonacci 61.8% 133.43
Fibonacci 50% 116.18
Fibonacci 38.2% 98.94
52-Week Low 43.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar